Jan 09, 2023 7:00am EST Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
Dec 08, 2022 6:30am EST Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
Dec 02, 2022 7:30am EST Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
Nov 11, 2022 9:00am EST Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
Nov 09, 2022 7:00am EST Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update